ProPhase Labs’ Nebula Genomics introduces lowest NGS pricing

ProPhase Labs announced that its wholly owned subsidiary, Nebula Genomics, has introduced its lowest ever standard price of $249.00 for its direct-to-consumer whole genome sequencing DNA test. "With limited competing products that offer standard pricing between $400-$1100, Nebula Genomics’ new standard price is the most affordable in the United States for 30X WGS and further cements us as a leader in DTC WGS services," commented Ted Karkus, ProPhase Labs’ Chief Executive Officer. "Our mission at Nebula is to usher in a new era of personal genomics by providing access to affordable and secure whole genome sequencing, and today’s announcement marks strong progress toward this goal," continued Karkus. "It’s our view that the future of health and wellness is personalized therapies based on each individual’s genetic makeup, and our WGS services, now more accessible than ever, enables that future. We seek to harness the power of the entire human genome, while delivering as much value as possible to our customers."